Askpot
← Company directory

Korecyte Bio: Summary

Korecyte Bio is a cell therapy startup focused on developing next-generation CAR-T cellular immunotherapies. Their mission is to create safe and effective treatments for solid cancers, improving outcomes for patients.

Service Name

Korecyte Bio

Industry

Biotechnology, Healthcare, Cancer Treatment, Immunotherapy

Main Value Proposition

Korecyte Bio offers innovative CAR-T immunotherapy solutions that aim to safely and effectively treat solid tumors, providing hope for better patient outcomes.

Description

Korecyte Bio is a cell therapy startup focused on developing next-generation CAR-T cellular immunotherapies. Their mission is to create safe and effective treatments for solid cancers, improving outcomes for patients.

Key Features

Ground-breaking modular platform technology ‘HypoxiCAR’; Ability to genetically engineer immune cells to target cancer; Modified immune cells that lay dormant until they detect a tumor; Significantly lowers toxic side effects of therapies

Use Cases

Korecyte's therapies are most valuable for patients with solid tumors seeking innovative and effective cancer treatments, as well as healthcare providers looking for advanced immunotherapy options.

Competitive advantages

Innovative approach to CAR-T therapy with reduced toxicity; Focus on solid tumors, a challenging area in cancer treatment; Commitment to patient safety and improved treatment outcomes

Strengths

Korecyte Bio's strengths lie in its cutting-edge technology, a dedicated international team, and a strong mission to improve cancer treatment options for patients.

Positioning

Korecyte Bio positions itself as a pioneering biotech company dedicated to developing next-generation immunotherapies that address the unmet needs in cancer treatment.

Audience

The target users include cancer patients, oncologists, and healthcare providers who are looking for advanced treatment options for solid tumors.

CTA

Find out more or get in touch with our team

Tags
  • CAR-T therapy

  • cancer treatment

  • immunotherapy

  • biotechnology

Tagline

Protecting tomorrow by getting to the core of cancer

Tone of Voice

Innovative, compassionate, professional

Differentiation

Korecyte's unique HypoxiCAR technology allows immune cells to remain dormant until they encounter cancer cells, enhancing their effectiveness while minimizing side effects, setting them apart from traditional therapies.

Brand Positioning

Korecyte Bio identifies itself as a compassionate and innovative leader in the biotech industry, focused on eradicating cancer and providing hope to patients worldwide.

Founded

2023-04-26

Founders
  • James Arnold

  • Léon Spijkers